- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04336995
Exercise Pulmonary Transit Time
April 5, 2024 updated by: Ken Monahan, Vanderbilt University Medical Center
Echocardiographic Assessment of Pulmonary Transit Time Following Exercise
The study seeks to measure pulmonary transit time via contrast-echocardiography before and after exercise.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The ability to measure the amount of blood in the lungs using heart-ultrasound (echocardiography) can be useful to estimate how much fluid is in a patient's circulation, which can influence diagnosis and treatment of certain types of heart failure.
In some patients, the amount of fluid is normal at rest, but can increase with activity and thus a diagnosis of heart failure can only be made after exercising.
Currently, the amount of fluid is measured invasively.
We have shown that echocardiography can measure the amount of fluid in the lung circulation at rest without the need for an invasive procedure.
We now seek to find out if we can make a similar measurement after exercise.
If successful, the need for catheter procedures may be reduced in certain types of heart failure.
Study Type
Interventional
Enrollment (Actual)
14
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Tennessee
-
Nashville, Tennessee, United States, 37232
- VHVI
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Age ≥ 18 years old
- Able to give informed consent
Exclusion Criteria:
- Known allergic reaction to Definity or Optison ultrasound contrast
- Pregnancy/Nursing - as assessed/disclosed by the participant
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Exercise
Everyone is in this arm
|
giving echocardiographic contrast and taking echocardiographic images before and after exercise
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pulmonary Transit Time
Time Frame: 3-10 seconds
|
interval required for the pulmonary blood volume to traverse the pulmonary circulation
|
3-10 seconds
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Ken Monahan, MD, VUMC
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 27, 2020
Primary Completion (Actual)
August 25, 2021
Study Completion (Actual)
March 1, 2024
Study Registration Dates
First Submitted
April 3, 2020
First Submitted That Met QC Criteria
April 3, 2020
First Posted (Actual)
April 7, 2020
Study Record Updates
Last Update Posted (Actual)
April 9, 2024
Last Update Submitted That Met QC Criteria
April 5, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB200429
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Yes
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Failure, Diastolic
-
Emory UniversityUnknownDiastolic Heart Failure | Diastolic DysfunctionUnited States
-
CorAssist Cadiovascular Ltd.RecruitingDiastolic Heart Failure | Diastolic DysfunctionIsrael
-
University of VermontCompletedDiastolic Heart Failure | Diastolic Dysfunction | PacemakerUnited States
-
University of NebraskaTerminatedDiastolic Heart FailureUnited States
-
Arizona State UniversityMayo Clinic; University of AlbertaCompleted
-
University of Wisconsin, MadisonTerminatedDiastolic Heart FailureUnited States
-
University of PennsylvaniaCompletedHeart Failure | Diastolic Heart FailureUnited States
-
Chang Gung Memorial HospitalCompleted
-
Duke UniversityNational Heart, Lung, and Blood Institute (NHLBI); PfizerCompleted
-
St Vincent's University Hospital, IrelandCompletedThe Effect of Eplerenone and Atorvastatin on Markers of Collagen Turnover in Diastolic Heart FailureDiastolic Heart FailureIreland
Clinical Trials on contrast echocardiography
-
Mayo ClinicGE HealthcareCompletedHypertrophic CardiomyopathyUnited States
-
Centre Hospitalier Universitaire de NīmesCompletedBrain InfarctionFrance
-
AcusphereCompletedCoronary Artery DiseaseUnited States
-
AcusphereCompletedCoronary Artery DiseaseUnited States
-
University Hospital, BordeauxUnknown
-
University of UtahCompletedAtrial FibrillationUnited States
-
Oregon Health and Science UniversityUnknownCoronary Artery DiseaseUnited States
-
Ottawa Heart Institute Research CorporationRecruitingAtrial FibrillationCanada
-
London North West Healthcare NHS TrustWithdrawnMyocardial Ischemia | Diagnostic ImagingUnited Kingdom
-
Harald BecherAlberta Health services; University of AlbertaCompleted